Bill > S00504

This bill prohibits cost sharing for insulin. It provides that an insured person shall not be subject to a deductible, copayment, coinsurance, or any other cost-sharing requirement for the purchase of insulin. The bill amends sections of the New York insurance law to remove the existing cap of $100 per 30-day supply on the amount an insured person must pay out-of-pocket for covered prescription insulin drugs. The bill will take effect on January 1, 2025 and apply to policies or contracts issued, renewed, modified, altered, or amended on or after that date.

Business and Industry

https://www.nysenate.gov/legislation/bills/2023/S504